This article talks about some people who work in a big company buying more shares of their own company because they think it's a good idea. These people are called insiders, and when they buy more shares, it can be a sign that the company is doing well or the price is low. This might make other people want to buy shares too. The article mentions four companies where these insiders have been buying shares recently, including Exelixis, which is a health care stock. Read from source...

- The article title is misleading and sensationalized, as it implies that insiders are buying more of a specific stock than they actually are. It does not mention the number or percentage of shares purchased relative to the total outstanding shares or market capitalization.

Positive

Explanation: The article discusses insider purchases of health care stocks, specifically Exelixis, Inc., indicating confidence in the company and its prospects. This suggests a positive sentiment towards these stocks, as it implies that insiders believe they are undervalued or have strong growth potential. Additionally, the title "Check Out These 4 Stocks Insiders Are Buying" also implies a bullish outlook on these stocks.

Based on the information provided in the article, here are my comprehensive investment recommendations and risks for each of the four stocks mentioned:

1. Exelixis (NASDAQ:EXEL):
- Recommendation: Buy - The director's purchase of $8.73 million worth of shares indicates a strong belief in the company's future prospects and the potential of its lead drug, cabozantinib, for treating various cancers. Exelixis has also reported positive clinical data for cabo